Overviews

Psychedelic Research Recap April 2024

April 2024 psychedelic research explores mechanisms, addresses challenges, compares MDMA to amphetamines, reviews 5-MeO-DMT, and investigates novel therapeutic applications for seizures, personality disorders, and cluster headaches.

Psychedelic Research Recap February 2024

What happens if psychedelics become a regular part of therapy? In a way, that is what the majority of research on psychedelics is trying to answer. Studies analysing the safety, to mapping out the effectiveness in various domains, including those featured here in February, help us understand psychedelics as medicines.

Psychedelic Research Recap January 2024

January saw new psychedelic trials on ibogaine for TBI, DMT, and psilocybin for CCHs, alongside re-analyses on psychedelic brain impacts, therapy dynamics in MDMA treatment, and LSD visuals. Studies also probed SSRI-psychedelic interactions, expectancy roles, and heart effects from microdosing.

Psychedelic Research Recap November 2023

November’s psychedelic research saw advances in ayahuasca formulations and intriguing survey findings on naturalistic use. The month also featured complex mechanisms and tracking psychedelic states via heart rate dynamics.